Will the Decade of Vaccines Mean Business as Usual?

The authors of this article, published in The Lancet, argue that anticipated advances in vaccinology during this new Decade of Vaccines (named by the Bill & Melinda Gates Foundation in January 2010) will only translate into reductions in global morbidity and mortality from targeted illnesses if fundamental restructuring means that the most marginalized countries (particularly in Africa and southeast Asia) gain access to new and established vaccines. They assert that there must be dialogue with various stakeholders, including the World Health Organization, civil society, governments, the private sector, and donor agencies in order to appropriately address all of the complexities of immunization.

Author: Rees H, Madhi SA

Published: 2011

» Visit web page (English)

(Located at

Citation: Rees H, Madhi SA. Will the Decade of Vaccines Mean Business as Usual? The Lancet. 2011;378(9789):382-385.

Resource types: Peer-reviewed journal

Diseases/vaccines: Not disease/vaccine specific

Topics: Advocacy and communications, Introduction and service delivery, Immunization financing

Regions: Global